Does CARFILZOMIB Cause Embolism? 50 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Embolism have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.2% of all adverse event reports for CARFILZOMIB.
50
Reports of Embolism with CARFILZOMIB
0.2%
of all CARFILZOMIB reports
22
Deaths
19
Hospitalizations
How Dangerous Is Embolism From CARFILZOMIB?
Of the 50 reports, 22 (44.0%) resulted in death, 19 (38.0%) required hospitalization, and 12 (24.0%) were considered life-threatening.
Is Embolism Listed in the Official Label?
Yes, Embolism is listed as a known adverse reaction in the official FDA drug label for CARFILZOMIB.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Embolism?
BEVACIZUMAB (378)
PACLITAXEL (251)
LENALIDOMIDE (206)
DEXAMETHASONE (204)
RITUXIMAB (204)
CYCLOPHOSPHAMIDE (202)
DOXORUBICIN (198)
RIVAROXABAN (197)
CARBOPLATIN (187)
APIXABAN (181)
Which CARFILZOMIB Alternatives Have Lower Embolism Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL